Part of the HELP.CH ® Network
Swiss News Now is a news platform with the latest news and information from Swiss companies and Swiss authorities. Latest news from Switzerland in English.
Bookings rose by 34.4% to CHF 201.7 million (H1 2025/26: CHF 150.1 million), driven primarily by Automation, Renewable Energy and Energy Distribution & High Precision. The book-to-bill ratio reached 1.16, pointing to a gradual recovery in demand.
More than 300,000 people in the UK are living with Tourette syndrome - a neurological disorder that can cause sudden, involuntary and repetitive movements and sounds known as tics.
Composable platform enables wealth managers to connect fragmented investment data, scale personalized portfolio management and add capabilities without replacing their existing technology stack.
Zug, Switzerland – The Board of COFRA Holding AG (“COFRA”) announces the appointment of Georg Wunderlin as Chief Executive Officer (CEO) and a member of the COFRA Board of Directors, effective in April 2027.
Swiss Re reported a net income of USD 1.3 billion for the third quarter of 2026, resulting in a net income of USD 4.2 billion and a return on equity (ROE) of 22.5% for the first nine months of the year. The Group's financial performance benefited from strong contributions from all Business Units, supported by lower-than-expected natural catastrophe losses and a solid investment result. The Group and all Business Units are well on track towards their 2026 financial targets.
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass. -- Molecular Partners AG (SIX, NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of medicines known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced the presentation of new preclinical data supporting an attractive therapeutic window for MP0632, a logic-gated Switch-DARPin T cell engager (TCE) with integrated CD2 co-stimulation, at the Society for Immunotherapy of Cancer (SITC) 2026 conference.
Allschwil, Switzerland – Idorsia Ltd (SIX: IDIA) today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to daridorexant for the treatment of insomnia disorder in patients 10 to <18 years of age.
SAN CARLOS, Calif.-- BeOne Medicines Ltd. a global oncology company, today announced financial results and corporate updates from the third quarter of 2026.
Schindellegi - Kuehne+Nagel announces three management appointments in key markets. Daniel Randig has been appointed National Manager for the United States of America, effective November 1, 2026. Björn Traemann will become National Manager for Germany and Miguel Germano Cluster Manager for Spain, Portugal and Malta, both effective January 1, 2027.
From the very beginning, Rado has been driven by a powerful belief: progress has no limits. Guided by a deep commitment to research and development in both materials and design, the brand has continually challenged the boundaries of what is possible, opening new territories and redefining the future of watchmaking.
Medacta Group SA (“Medacta,” SIX: MOVE) today updates its FY 2026 guidance and reaffirms the 2024-2027 mid-term outlook.
SwissNewsNow.com is a news platform focused on current developments from Switzerland and part of the
HELP.CH ® network.
The platform provides readers with a compact overview of Swiss news, business developments, company information, innovation, technology and society. Selected content is sourced from the HELP.CH news network and related media platforms.
SwissNewsNow.com helps make important Swiss news accessible through structured publication, search engine visibility and distribution across digital channels.
More about the network:
help.swiss/en
The network includes news platforms such as Aktuellenews.ch, HELP.CH News, Swiss-Press.com, Tagesthemen.ch, Aktuellenews.de and Aktuellenews.at. Together they provide coverage of Swiss business, technology, innovation, society and economic developments.
SwissNewsNow.com brings together selected news and information from across the network, providing readers with a convenient gateway to relevant Swiss topics and current developments.